Taken together, these data offer a possible explanation for the difference of IL-23/IL-22 pathway in clinical behaviour of the two variants of the disease and support the hypothesis that different immunopathogenetic mechanisms might be involved in the two variants of OLP. The gene discussed is IL23A; the disease is oral lichen planus.